low economyUNVERIFIED
Antibiotice Iasi Seeks Shareholder Approval For Up To RON250M Non-Recourse Factoring Facility From Banca Transilvania
Only one outlet has reported this so far: treat it as unconfirmed.
📍 Iasi, RO·🕐 19h ago·1 outlet
Pharmaceutical manufacturer Antibiotice Iasi (stock symbol: ATB), controlled by the Ministry of Health, has convened its shareholders for December 17 to approve a non-recourse factoring facility of up to RON250 million (EUR47 million) from lender Banca Transilvania.
How sure are we
1 outlet
Only one outlet so far: treat it as unconfirmed. That doesn’t make it false; it may be new, or an exclusive.
Who reported it
This report
View original source →Location
Verification Log
No verification data yet
Checks run automatically as new sources are ingested.
Reliability
Reliability ScoreVery high
83%Independent outlets1
Statusnot yet verified
AI checknone yet
Community flags0
Score bands
Very high80–100%
A highly rated outlet, or several independent outletsHigh60–79%
One well-rated outlet so farModerate40–59%
A lower-rated or state-run outlet, or one report of something seriousLow20–39%
A low-rated outlet on a serious or sensitive storyVery low0–19%
Treat it as unconfirmedWhat moves the score
◎
Outlet ratingThe outlet’s rating in WorldPulse’s list of sources starts the score
⇄
Independent outletsEach further outlet that reports the story closes 40% of the gap to 98%
±
Report detailsA few points either way: a summary and a place add a little; state-run outlets on conflict, politics or security, and single reports marked high or critical, lose some
Not in the score: AI checks and reader flags. Verified is separate: two or more independent outlets and a score of at least 65%.
Very high · How we score this
Risk Score
low risk